Back to Rankings

HROW

HarrowB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
HROW vs peer average
72/100
HROW vs. peer average (B vs. C)
Grade spread
B 2 · C 4 · D 4 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

AUPH is the first available peer comparator.

AUPH is closer on market cap than on business mix; it is a loose specialty-biopharma comparison rather than a direct ophthalmic commercial peer, so relative valuation read-through is limited.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAUPHAurinia
HROW
Harrow
AUPH
Aurinia
Grade
B
C
Momentum
74
27
Value
57
66
Sentiment
48
55
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs AUPH

HROW / AUPH
Grade Position
Above peers
HROW vs. peer average (B vs. C)
72/100
Momentum
74
HROW
Value
57
AUPH
Sentiment
48
AUPH

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HROW
1
AUPH
AUPH
C
60/100
+1
2
IBRX
IBRX
B
80/100
Even
3
REGN
REGN
B
80/100
Even
4
CMPS
COMPASS Pathways Plc ADR
D
40/100
+2
5
INVA
Innoviva Inc Common
C
60/100
+1
AUPH is the first peer returned for this comparison set.